Safety, Tolerability, PK and Efficacy of Single Doses of NV-5138 in Healthy Volunteers and Subjects With Treatment-Resistant Depression
Clinical trial NCT03606395 · COMPLETED
Trial details
- NCT number
- NCT03606395
- Sponsor
- Navitor Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-06
- Primary completion
- 2019-06-09
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.